Drugmaker Eisai Co. said Wednesday that its U.S. subsidiary, Eisai U.S.A. Inc., will close its vitamin factory in Pasadena, Texas.

Eisai U.S.A. will halt its bulk sales of synthetic vitamin E products to food manufacturers, according to the parent company.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.